Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · IEX Real-Time Price · USD
0.378
+0.070 (22.56%)
Jul 22, 2024, 10:15 AM EDT - Market open
Sonoma Pharmaceuticals Employees
Sonoma Pharmaceuticals had 10 employees as of March 31, 2024. The number of employees increased by 1 or 11.11% compared to the previous year.
Employees
10
Change (1Y)
1
Growth (1Y)
11.11%
Revenue / Employee
$1,273,500
Profits / Employee
-$483,500
Market Cap
6.65M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
PolyPid | 62 |
Ainos | 46 |
Hepion Pharmaceuticals | 22 |
TFF Pharmaceuticals | 19 |
Soligenix | 15 |
Aethlon Medical | 14 |
Oragenics | 5 |
Titan Pharmaceuticals | 4 |
SNOA News
- 13 days ago - Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine - Accesswire
- 4 weeks ago - Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results - Accesswire
- 2 months ago - Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores - Accesswire
- 3 months ago - Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States - Accesswire
- 3 months ago - Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections - Accesswire
- 4 months ago - Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences - Accesswire
- 4 months ago - Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals - Accesswire
- 5 months ago - Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results - Accesswire